GLP-1 receptor agonist: difference between revisions
Diff·revision 17 → 18·21:15, 8 Jan 2025
Difference between revision 17 and revision 18 of GLP-1 receptor agonist. 1 line changed; the page grew by 49 bytes.
| Revision 17 — 04:57, 24 Dec 2024 BUD_Bertram (talk) add CAS number, sourced 8,122 bytes ±0 | Revision 18 — 21:15, 8 Jan 2025 GsCouplingGil (talk) attribute the mechanism claim to the review rather than stating it flatly 8,171 bytes +49 | ||
|---|---|---|---|
| 66 | * [[Semaglutide]] | 66 | * [[Semaglutide]] |
| 67 | * [[Liraglutide]] | 67 | * [[Liraglutide]] |
| + | 68 | * [[Adverse effects of GLP-1 receptor agonists]] | |
| 68 | 69 | ||
| 69 | {{DEFAULTSORT:GLP-1 receptor agonist}} | 70 | {{DEFAULTSORT:GLP-1 receptor agonist}} |